Profusa, Inc.

Profusa, Inc., trading under the SPAC ticker NVAC, is a healthcare technology company operating in the implantable biosensor space, focused on continuous biochemical monitoring via subcutaneous sensor platforms. The company filed a 10-Q with the SEC on August 14, 2023, reflecting its financial position and operational status as a publicly traded entity following its SPAC transaction. Profusa's platform targets real-time, in-body measurement of key biomarkers, placing it at the intersection of medical devices and digital health infrastructure. The filing represents a continued reporting obligation under the NVAC vehicle as the company advances its commercial and clinical programs. Sign up for SpacDesk to access the full filing history, deal timeline, and sponsor data for NVAC and hundreds of other SPAC transactions.